<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34535505</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">2373-2873</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Cold Spring Harbor molecular case studies</Title><ISOAbbreviation>Cold Spring Harb Mol Case Stud</ISOAbbreviation></Journal><ArticleTitle>A novel variant in <i>DYNC1H1</i> could contribute to human amyotrophic lateral sclerosis-frontotemporal dementia spectrum.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">a006096</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/mcs.a006096</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) belongs to the ALS-frontotemporal dementia (FTD) spectrum and is hallmarked by upper and lower motor neuron degeneration. Here, we present a patient with a cytoplasmic dynein 1 heavy chain 1 (<i>DYNC1H1</i>) pathogenic variant who fulfilled the ALS El Escorial criteria, and we review relevant literature. Using whole-exome sequencing, we identified a deleterious point variant in <i>DYNC1H1</i> (c.4106A &gt; G (p. Q1369R)) as a likely contributor to the ALS phenotype. In silico structural analysis, molecular dynamics simulation, and protein stability analysis predicted that this variant may increase DYNC1H1 protein stability. Moreover, this variant may disrupt binding of the transcription factor TFAP4, thus potentially acting as duon. Because (a) DYNC1H1 forms part of a ubiquitous eukaryotic motor protein complex, and (b) disruption of dynein function by perturbation of the dynein-dynactin protein complex is implicated in other motor neuron degenerative conditions, this variant could disrupt processes like retrograde axonal transport, neuronal migration, and protein recycling. Our findings expand the heterogenous spectrum of the <i>DYNC1H1</i> pathogenic variant-associated phenotype and prompt further investigations of the role of this gene in ALS.</AbstractText><CopyrightInformation>&#xa9; 2022 Mentis et al.; Published by Cold Spring Harbor Laboratory Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mentis</LastName><ForeName>Alexios-Fotios A</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0002-1480-390X</Identifier><AffiliationInfo><Affiliation>Public Health Laboratories, Hellenic Pasteur Institute, Athens 115 21, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Research Institute of Maternal and Child Health &amp; Precision Medicine, and UNESCO Chair on Adolescent Health Care, "Aghia Sophia" Children's Hospital, Athens 115 27, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical School, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, Athens 115 27, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Neurogenetics, Department of Neurology, School of Medicine, University Hospital of Larissa, University of Thessaly, Larissa 413 34, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vlachakis</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University Research Institute of Maternal and Child Health &amp; Precision Medicine, and UNESCO Chair on Adolescent Health Care, "Aghia Sophia" Children's Hospital, Athens 115 27, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Genetics, Department of Biotechnology, School of Applied Biology and Biotechnology, Agricultural University of Athens, Athens 118 55, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Endocrinology and Metabolism, Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 115 27, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papakonstantinou</LastName><ForeName>Eleni</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Laboratory of Genetics, Department of Biotechnology, School of Applied Biology and Biotechnology, Agricultural University of Athens, Athens 118 55, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaganas</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Neurogenetics Laboratory, Medical School, University of Crete, Heraklion, Crete 715 00, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Department, University Hospital of Crete, Heraklion, Crete 715 00, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patrinos</LastName><ForeName>George P</ForeName><Initials>GP</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, University of Patras School of Health Sciences, Patras 265 34, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain 155 51, United Arab Emirates.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Zayed Center of Health Sciences, United Arab Emirates University, Al-Ain 155 51, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chrousos</LastName><ForeName>George P</ForeName><Initials>GP</Initials><AffiliationInfo><Affiliation>University Research Institute of Maternal and Child Health &amp; Precision Medicine, and UNESCO Chair on Adolescent Health Care, "Aghia Sophia" Children's Hospital, Athens 115 27, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dardiotis</LastName><ForeName>Efthimios</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Laboratory of Neurogenetics, Department of Neurology, School of Medicine, University Hospital of Larissa, University of Thessaly, Larissa 413 34, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cold Spring Harb Mol Case Stud</MedlineTA><NlmUniqueID>101660017</NlmUniqueID><ISSNLinking>2373-2873</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C511240">DYNC1H1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.2</RegistryNumber><NameOfSubstance UI="D056445">Cytoplasmic Dyneins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.2</RegistryNumber><NameOfSubstance UI="D004398">Dyneins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056445" MajorTopicYN="N">Cytoplasmic Dyneins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004398" MajorTopicYN="N">Dyneins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073359" MajorTopicYN="N">Exome Sequencing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>18</Day><Hour>5</Hour><Minute>40</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34535505</ArticleId><ArticleId IdType="pmc">PMC8958913</ArticleId><ArticleId IdType="doi">10.1101/mcs.a006096</ArticleId><ArticleId IdType="pii">mcs.a006096</ArticleId><ArticleId IdType="medline">MCS006096Men</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abramzon YA, Fratta P, Traynor BJ, Chia R. 2020. The overlapping genetics of amyotrophic lateral sclerosis and frontotemporal dementia. Front Neurosci 14: 42. 10.3389/fnins.2020.00042</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00042</ArticleId><ArticleId IdType="pmc">PMC7012787</ArticleId><ArticleId IdType="pubmed">32116499</ArticleId></ArticleIdList></Reference><Reference><Citation>Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. 2010. A method and server for predicting damaging missense mutations. Nat Methods 7: 248&#x2013;249. 10.1038/nmeth0410-248</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth0410-248</ArticleId><ArticleId IdType="pmc">PMC2855889</ArticleId><ArticleId IdType="pubmed">20354512</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Calvo A, Chio A, Colville S, Ellis CM, Hardiman O, Heverin M, Howard RS, Huisman MHB, Keren N, et al. 2014. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol 13: 1108&#x2013;1113. 10.1016/S1474-4422(14)70219-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70219-4</ArticleId><ArticleId IdType="pmc">PMC4197338</ArticleId><ArticleId IdType="pubmed">25300936</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, van den Berg LH, Veldink J. 2017. Gene discovery in amyotrophic lateral sclerosis: implications for clinical management. Nat Rev Neurol 13: 96. 10.1038/nrneurol.2016.182</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.182</ArticleId><ArticleId IdType="pubmed">27982040</ArticleId></ArticleIdList></Reference><Reference><Citation>Amabile S, Jeffries L, McGrath JM, Ji W, Spencer-Manzon M, Zhang H, Lakhani SA. 2020. DYNC1H1-related disorders: a description of four new unrelated patients and a comprehensive review of previously reported variants. Am J Med Genet A 182: 2049&#x2013;2057. 10.1002/ajmg.a.61729</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.a.61729</ArticleId><ArticleId IdType="pubmed">32656949</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosini G, Vorontsov I, Penzar D, Groux R, Fornes O, Nikolaeva DD, Ballester B, Grau J, Grosse I, Makeev V, et al. 2020. Insights gained from a comprehensive all-against-all transcription factor binding motif benchmarking study. Genome Biol 21: 1&#x2013;18. 10.1186/s13059-020-01996-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-020-01996-3</ArticleId><ArticleId IdType="pmc">PMC7212583</ArticleId><ArticleId IdType="pubmed">32393327</ArticleId></ArticleIdList></Reference><Reference><Citation>Andr&#xe9;s-Benito P, Povedano M, Torres P, Portero-Otin M, Ferrer I. 2019. Altered dynein axonemal assembly factor 1 expression in C-boutons in bulbar and spinal cord motor-neurons in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 78: 416&#x2013;425. 10.1093/jnen/nlz019</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlz019</ArticleId><ArticleId IdType="pubmed">30939186</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur KC, Calvo A, Price TR, Geiger JT, Chi&#xf2; A, Traynor BJ. 2016. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun 7: 12408. 10.1038/ncomms12408</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12408</ArticleId><ArticleId IdType="pmc">PMC4987527</ArticleId><ArticleId IdType="pubmed">27510634</ArticleId></ArticleIdList></Reference><Reference><Citation>Audano PA, Sulovari A, Graves-Lindsay TA, Cantsilieris S, Sorensen M, Welch AE, Dougherty ML, Nelson BJ, Shah A, Dutcher SK, et al. 2019. Characterizing the major structural variant alleles of the human genome. Cell 176: 663&#x2013;675.e619. 10.1016/j.cell.2018.12.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.12.019</ArticleId><ArticleId IdType="pmc">PMC6438697</ArticleId><ArticleId IdType="pubmed">30661756</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayalew M, Le-Niculescu H, Levey D, Jain N, Changala B, Patel S, Winiger E, Breier A, Shekhar A, Amdur R, et al. 2012. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol Psychiatry 17: 887&#x2013;905. 10.1038/mp.2012.37</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2012.37</ArticleId><ArticleId IdType="pmc">PMC3427857</ArticleId><ArticleId IdType="pubmed">22584867</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandres-Ciga S, Noyce AJ, Hemani G, Nicolas A, Calvo A, Mora G, Tienari PJ, Stone DJ, Nalls MA, Singleton AB, et al. 2019. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. Ann Neurol 85: 470&#x2013;481. 10.1002/ana.25431</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25431</ArticleId><ArticleId IdType="pmc">PMC6450729</ArticleId><ArticleId IdType="pubmed">30723964</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker L-L, Dafsari HS, Schallner J, Abdin D, Seifert M, Petit F, Smol T, Bok L, Rodan L, Krapels I, et al. 2020. The clinical-phenotype continuum in DYNC1H1-related disorders&#x2014;genomic profiling and proposal for a novel classification. J Hum Genet 65: 1003&#x2013;1017. 10.1038/s10038-020-0803-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s10038-020-0803-1</ArticleId><ArticleId IdType="pmc">PMC7719554</ArticleId><ArticleId IdType="pubmed">32788638</ArticleId></ArticleIdList></Reference><Reference><Citation>Belbasis L, Bellou V, Evangelou E. 2016. Environmental risk factors and amyotrophic lateral sclerosis: an umbrella review and critical assessment of current evidence from systematic reviews and meta-analyses of observational studies. Neuroepidemiology 46: 96&#x2013;105. 10.1159/000443146</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000443146</ArticleId><ArticleId IdType="pubmed">26731747</ArticleId></ArticleIdList></Reference><Reference><Citation>Bercier V, Hubbard JM, Fidelin K, Duroure K, Auer TO, Revenu C, Wyart C, Del Bene F. 2019. Dynactin1 depletion leads to neuromuscular synapse instability and functional abnormalities. Mol Neurodegener 14: 27. 10.1186/s13024-019-0327-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0327-3</ArticleId><ArticleId IdType="pmc">PMC6617949</ArticleId><ArticleId IdType="pubmed">31291987</ArticleId></ArticleIdList></Reference><Reference><Citation>Cady J, Allred P, Bali T, Pestronk A, Goate A, Miller TM, Mitra RD, Ravits J, Harms MB, Baloh RH. 2015. Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes. Ann Neurol 77: 100&#x2013;113. 10.1002/ana.24306</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24306</ArticleId><ArticleId IdType="pmc">PMC4293318</ArticleId><ArticleId IdType="pubmed">25382069</ArticleId></ArticleIdList></Reference><Reference><Citation>Capriotti E, Fariselli P, Casadio R. 2005. I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res 33: W306&#x2013;W310. 10.1093/nar/gki375</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gki375</ArticleId><ArticleId IdType="pmc">PMC1160136</ArticleId><ArticleId IdType="pubmed">15980478</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho MD, Swash M. 2009. Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis. Amyotroph Lateral Scler 10: 53&#x2013;57. 10.1080/17482960802521126</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802521126</ArticleId><ArticleId IdType="pubmed">18985466</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Sayana P, Zhang X, Le W. 2013. Genetics of amyotrophic lateral sclerosis: an update. Mol Neurodegener 8: 28. 10.1186/1750-1326-8-28</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-8-28</ArticleId><ArticleId IdType="pmc">PMC3766231</ArticleId><ArticleId IdType="pubmed">23941283</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng J, Randall A, Baldi P. 2006. Prediction of protein stability changes for single-site mutations using support vector machines. Proteins 62: 1125&#x2013;1132. 10.1002/prot.20810</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.20810</ArticleId><ArticleId IdType="pubmed">16372356</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Chio A, Traynor BJ. 2018. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol 17: 94&#x2013;102. 10.1016/S1474-4422(17)30401-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Claussnitzer M, Dankel SN, Kim K-H, Quon G, Meuleman W, Haugen C, Glunk V, Sousa IS, Beaudry JL, Puviindran V, et al. 2015. FTO Obesity variant circuitry and adipocyte browning in humans. N Engl J Med 373: 895&#x2013;907. 10.1056/NEJMoa1502214</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1502214</ArticleId><ArticleId IdType="pmc">PMC4959911</ArticleId><ArticleId IdType="pubmed">26287746</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly S, Galvin M, Hardiman O. 2015. End-of-life management in patients with amyotrophic lateral sclerosis. Lancet Neurol 14: 435&#x2013;442. 10.1016/S1474-4422(14)70221-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70221-2</ArticleId><ArticleId IdType="pubmed">25728958</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado L, Mazzini L, Oggioni GD, Luciano B, Godi M, Brusco A, D'Alfonso S. 2011. ATXN-2 CAG repeat expansions are interrupted in ALS patients. Hum Genet 130: 575&#x2013;580. 10.1007/s00439-011-1000-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-011-1000-2</ArticleId><ArticleId IdType="pubmed">21537950</ArticleId></ArticleIdList></Reference><Reference><Citation>Courchesne SL, Pazyra-Murphy MF, Lee DJ, Segal RA. 2011. Neuromuscular junction defects in mice with mutation of dynein heavy chain 1. PLoS One 6: e16753. 10.1371/journal.pone.0016753</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0016753</ArticleId><ArticleId IdType="pmc">PMC3035627</ArticleId><ArticleId IdType="pubmed">21346813</ArticleId></ArticleIdList></Reference><Reference><Citation>Davydov EV, Goode DL, Sirota M, Cooper GM, Sidow A, Batzoglou S. 2010. Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLoS Comput Biol 6: e1001025. 10.1371/journal.pcbi.1001025</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1001025</ArticleId><ArticleId IdType="pmc">PMC2996323</ArticleId><ArticleId IdType="pubmed">21152010</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vries BS, Rustemeijer LMM, Bakker LA, Schr&#xf6;der CD, Veldink JH, van den Berg LH, Nijboer TCW, van Es MA. 2019. Cognitive and behavioural changes in PLS and PMA: challenging the concept of restricted phenotypes. J Neurol Neurosurg Psychiatry 90: 141&#x2013;147. 10.1136/jnnp-2018-318788</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318788</ArticleId><ArticleId IdType="pubmed">30076267</ArticleId></ArticleIdList></Reference><Reference><Citation>Dror RO, Dirks RM, Grossman J, Xu H, Shaw DE. 2012. Biomolecular simulation: a computational microscope for molecular biology. Annu Rev Biophys 41: 429&#x2013;452. 10.1146/annurev-biophys-042910-155245</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biophys-042910-155245</ArticleId><ArticleId IdType="pubmed">22577825</ArticleId></ArticleIdList></Reference><Reference><Citation>Ewing B, Green P. 1998. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res 8: 186&#x2013;194. 10.1101/gr.8.3.186</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.8.3.186</ArticleId><ArticleId IdType="pubmed">9521922</ArticleId></ArticleIdList></Reference><Reference><Citation>Fergani A, Eschbach J, Oudart H, Larmet Y, Schwalenstocker B, Ludolph AC, Loeffler J-P, Dupuis L. 2011. A mutation in the dynein heavy chain gene compensates for energy deficit of mutant SOD1 mice and increases potentially neuroprotective IGF-1. Mol Neurodegener 6: 26. 10.1186/1750-1326-6-26</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-6-26</ArticleId><ArticleId IdType="pmc">PMC3111394</ArticleId><ArticleId IdType="pubmed">21521523</ArticleId></ArticleIdList></Reference><Reference><Citation>Galdadas I, Gervasio FL, Cournia Z. 2020. Unravelling the effect of the E545K mutation on PI3K&#x3b1; kinase. Chem Sci 11: 3511&#x2013;3515. 10.1039/C9SC05903B</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C9SC05903B</ArticleId><ArticleId IdType="pmc">PMC8493679</ArticleId><ArticleId IdType="pubmed">34703536</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrett CA, Barri M, Kuta A, Soura V, Deng W, Fisher EM, Schiavo G, Hafezparast M. 2014. DYNC1H1 mutation alters transport kinetics and ERK1/2-cFos signalling in a mouse model of distal spinal muscular atrophy. Brain 137: 1883&#x2013;1893. 10.1093/brain/awu097</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu097</ArticleId><ArticleId IdType="pubmed">24755273</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-P&#xe9;rez A, L&#xf3;pez-Bigas N. 2011. Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am J Hum Genet 88: 440&#x2013;449. 10.1016/j.ajhg.2011.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2011.03.004</ArticleId><ArticleId IdType="pmc">PMC3071923</ArticleId><ArticleId IdType="pubmed">21457909</ArticleId></ArticleIdList></Reference><Reference><Citation>Goulielmos GN, Zervou MI, Eliopoulos E. 2019. Functional significance of the C324R mutation examined using a structural biological approach. J Rheumatol 46: 654&#x2013;655. 10.3899/jrheum.181346</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.181346</ArticleId><ArticleId IdType="pubmed">31154448</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant CE, Bailey TL, Noble WS. 2011. FIMO: scanning for occurrences of a given motif. Bioinformatics 27: 1017&#x2013;1018. 10.1093/bioinformatics/btr064</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btr064</ArticleId><ArticleId IdType="pmc">PMC3065696</ArticleId><ArticleId IdType="pubmed">21330290</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafezparast M, Klocke R, Ruhrberg C, Marquardt A, Ahmad-Annuar A, Bowen S, Lalli G, Witherden AS, Hummerich H, Nicholson S, et al. 2003. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300: 808&#x2013;812. 10.1126/science.1083129</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1083129</ArticleId><ArticleId IdType="pubmed">12730604</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH. 2017. Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3: 17071. 10.1038/nrdp.2017.71</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Harms MB, Ori-McKenney KM, Scoto M, Tuck EP, Bell S, Ma D, Masi S, Allred P, Al-Lozi M, Reilly MM, et al. 2012. Mutations in the tail domain of DYNC1H1 cause dominant spinal muscular atrophy. Neurology 78: 1714&#x2013;1720. 10.1212/WNL.0b013e3182556c05</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182556c05</ArticleId><ArticleId IdType="pmc">PMC3359582</ArticleId><ArticleId IdType="pubmed">22459677</ArticleId></ArticleIdList></Reference><Reference><Citation>Helferich AM, Brockmann SJ, Reinders J, Deshpande D, Holzmann K, Brenner D, Andersen PM, Petri S, Thal DR, Michaelis J, et al. 2018. Dysregulation of a novel miR-1825/TBCB/TUBA4A pathway in sporadic and familial ALS. Cell Mol Life Sci 75: 4301&#x2013;4319. 10.1007/s00018-018-2873-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-018-2873-1</ArticleId><ArticleId IdType="pubmed">30030593</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang HT, Schlager MA, Carter AP, Bullock SL. 2017. DYNC1H1 mutations associated with neurological diseases compromise processivity of dynein-dynactin-cargo adaptor complexes. Proc Natl Acad Sci 114: E1597&#x2013;E1606. 10.1073/pnas.1620141114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1620141114</ArticleId><ArticleId IdType="pmc">PMC5338514</ArticleId><ArticleId IdType="pubmed">28196890</ArticleId></ArticleIdList></Reference><Reference><Citation>Ionita-Laza I, McCallum K, Xu B, Buxbaum JD. 2016. A spectral approach integrating functional genomic annotations for coding and noncoding variants. Nat Genet 48: 214. 10.1038/ng.3477</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3477</ArticleId><ArticleId IdType="pmc">PMC4731313</ArticleId><ArticleId IdType="pubmed">26727659</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeggari A, Marks DS, Larsson E. 2012. miRcode: a map of putative microRNA target sites in the long non-coding transcriptome. Bioinformatics 28: 2062&#x2013;2063. 10.1093/bioinformatics/bts344</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts344</ArticleId><ArticleId IdType="pmc">PMC3400968</ArticleId><ArticleId IdType="pubmed">22718787</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan MA, Diener DR, Stepanek L, Pigino G. 2018. The cryo-EM structure of intraflagellar transport trains reveals how dynein is inactivated to ensure unidirectional anterograde movement in cilia. Nat Cell Biol 20: 1250&#x2013;1255. 10.1038/s41556-018-0213-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-018-0213-1</ArticleId><ArticleId IdType="pubmed">30323187</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K, Martinez FJ, Yeo GW. 2017. Genetic mutations in RNA-binding proteins and their roles in ALS. Hum Genet 136: 1193&#x2013;1214. 10.1007/s00439-017-1830-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-017-1830-7</ArticleId><ArticleId IdType="pmc">PMC5602095</ArticleId><ArticleId IdType="pubmed">28762175</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaszkin-Bettag M, Hildebrandt W. 2012. Case reports on cancer therapies: the urgent need to improve the reporting quality. Glob Adv Health Med 1: 8&#x2013;10. 10.7453/gahmj.2012.1.2.002</Citation><ArticleIdList><ArticleId IdType="doi">10.7453/gahmj.2012.1.2.002</ArticleId><ArticleId IdType="pmc">PMC3833504</ArticleId><ArticleId IdType="pubmed">24278810</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJE. 2015. The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc 10: 845&#x2013;858. 10.1038/nprot.2015.053</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2015.053</ArticleId><ArticleId IdType="pmc">PMC5298202</ArticleId><ArticleId IdType="pubmed">25950237</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna KP, McLaughlin RL, Byrne S, Elamin M, Heverin M, Kenny EM, Cormican P, Morris DW, Donaghy CG, Bradley DG, et al. 2013. Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing. J Med Genet 50: 776&#x2013;783. 10.1136/jmedgenet-2013-101795</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2013-101795</ArticleId><ArticleId IdType="pmc">PMC3812897</ArticleId><ArticleId IdType="pubmed">23881933</ArticleId></ArticleIdList></Reference><Reference><Citation>Keogh MJ, Wei W, Aryaman J, Wilson I, Talbot K, Turner MR, McKenzie CA, Troakes C, Attems J, Smith C, et al. 2018. Oligogenic genetic variation of neurodegenerative disease genes in 980 postmortem human brains. J Neurol Neurosurg Psychiatry 89: 813&#x2013;816. 10.1136/jnnp-2017-317234</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317234</ArticleId><ArticleId IdType="pmc">PMC6204946</ArticleId><ArticleId IdType="pubmed">29332010</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiene H, Hamre HJ, Kienle GS. 2013. In support of clinical case reports: a system of causality assessment. Glob Adv Health Med 2: 64&#x2013;75. 10.7453/gahmj.2012.061</Citation><ArticleIdList><ArticleId IdType="doi">10.7453/gahmj.2012.061</ArticleId><ArticleId IdType="pmc">PMC3833527</ArticleId><ArticleId IdType="pubmed">24416665</ArticleId></ArticleIdList></Reference><Reference><Citation>Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J. 2014. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 46: 310&#x2013;315. 10.1038/ng.2892</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2892</ArticleId><ArticleId IdType="pmc">PMC3992975</ArticleId><ArticleId IdType="pubmed">24487276</ArticleId></ArticleIdList></Reference><Reference><Citation>Koushika SP, Schaefer AM, Vincent R, Willis JH, Bowerman B, Nonet ML. 2004. Mutations in Caenorhabditis elegans cytoplasmic dynein components reveal specificity of neuronal retrograde cargo. J Neurosci 24: 3907&#x2013;3916. 10.1523/JNEUROSCI.5039-03.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5039-03.2004</ArticleId><ArticleId IdType="pmc">PMC6729415</ArticleId><ArticleId IdType="pubmed">15102906</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulakovskiy IV, Vorontsov IE, Yevshin IS, Soboleva AV, Kasianov AS, Ashoor H, Ba-Alawi W, Bajic VB, Medvedeva YA, Kolpakov FA, et al. 2016. HOCOMOCO: expansion and enhancement of the collection of transcription factor binding sites models. Nucleic Acids Res 44: D116&#x2013;D125. 10.1093/nar/gkv1249</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv1249</ArticleId><ArticleId IdType="pmc">PMC4702883</ArticleId><ArticleId IdType="pubmed">26586801</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuuluvainen L, Kaivola K, M&#xf6;nk&#xe4;re S, Laaksovirta H, Jokela M, Udd B, Valori M, Pasanen P, Paetau A, Traynor BJ. 2019. Oligogenic basis of sporadic ALS: the example of SOD1 p. Ala90Val mutation. Neurol Genet 5: e335. 10.1212/NXG.0000000000000335</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000335</ArticleId><ArticleId IdType="pmc">PMC6481226</ArticleId><ArticleId IdType="pubmed">31086828</ArticleId></ArticleIdList></Reference><Reference><Citation>LaMonte BH, Wallace KE, Holloway BA, Shelly SS, Asca&#xf1;o J, Tokito M, Van Winkle T, Howland DS, Holzbaur EL. 2002. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34: 715&#x2013;727. 10.1016/S0896-6273(02)00696-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(02)00696-7</ArticleId><ArticleId IdType="pubmed">12062019</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S, Doronzio PN, Marangi G, Conte A, Bisogni G, Bernardo D, Russo T, Lamberti D, Patrizi S, Apollo FP, et al. 2019. Coexistence of variants in TBK1 and in other ALS-related genes elucidates an oligogenic model of pathogenesis in sporadic ALS. Neurobiol Aging 84: 239.e239&#x2013;239.e214. 10.1016/j.neurobiolaging.2019.03.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2019.03.010</ArticleId><ArticleId IdType="pubmed">31000212</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesgidou N, Eliopoulos E, Goulielmos GN, Vlassi M. 2018. Insights on the alteration of functionality of a tyrosine kinase 2 variant: a molecular dynamics study. Bioinformatics 34: i781&#x2013;i786. 10.1093/bioinformatics/bty556</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty556</ArticleId><ArticleId IdType="pubmed">30423093</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis TR, Zareba M, Link BA, Besharse JC. 2018. Cone myoid elongation involves unidirectional microtubule movement mediated by dynein-1. Mol Biol Cell 29: 180&#x2013;190. 10.1091/mbc.E17-08-0525</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E17-08-0525</ArticleId><ArticleId IdType="pmc">PMC5909930</ArticleId><ArticleId IdType="pubmed">29142075</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R, et al. 2009. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25: 2078&#x2013;2079. 10.1093/bioinformatics/btp352</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp352</ArticleId><ArticleId IdType="pmc">PMC2723002</ArticleId><ArticleId IdType="pubmed">19505943</ArticleId></ArticleIdList></Reference><Reference><Citation>MacArthur D, Manolio T, Dimmock D, Rehm H, Shendure J, Abecasis G, Adams D, Altman R, Antonarakis S, Ashley E, et al. 2014. Guidelines for investigating causality of sequence variants in human disease. Nature 508: 469&#x2013;476. 10.1038/nature13127</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13127</ArticleId><ArticleId IdType="pmc">PMC4180223</ArticleId><ArticleId IdType="pubmed">24759409</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzo MG, Griswold JM, Ruff KM, Buchmeier RE, Fees CP, Markus SM. 2019. Molecular basis for dyneinopathies reveals insight into dynein regulation and dysfunction. Elife 8: e47246. 10.7554/eLife.47246</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.47246</ArticleId><ArticleId IdType="pmc">PMC6733598</ArticleId><ArticleId IdType="pubmed">31364990</ArticleId></ArticleIdList></Reference><Reference><Citation>McCann EP, Henden L, Fifita JA, Zhang KY, Grima N, Bauer DC, Chan Moi Fat S, Twine NA, Pamphlett R, Kiernan MC, et al. 2021. Evidence for polygenic and oligogenic basis of Australian sporadic amyotrophic lateral sclerosis. J Med Genet 58: 87&#x2013;95. 10.1136/jmedgenet-2020-106866</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2020-106866</ArticleId><ArticleId IdType="pubmed">32409511</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M. 2010. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20: 1297&#x2013;1303. 10.1101/gr.107524.110</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.107524.110</ArticleId><ArticleId IdType="pmc">PMC2928508</ArticleId><ArticleId IdType="pubmed">20644199</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishima T, Fujioka S, Tomiyama H, Yabe I, Kurisaki R, Fujii N, Neshige R, Ross OA, Farrer MJ, Dickson DW, et al. 2018. Establishing diagnostic criteria for Perry syndrome. J Neurol Neurosurg Psychiatry 89: 482&#x2013;487. 10.1136/jnnp-2017-316864</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-316864</ArticleId><ArticleId IdType="pmc">PMC5909757</ArticleId><ArticleId IdType="pubmed">29089398</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore JK, Sept D, Cooper JA. 2009. Neurodegeneration mutations in dynactin impair dynein-dependent nuclear migration. Proc Natl Acad Sci 106: 5147&#x2013;5152. 10.1073/pnas.0810828106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0810828106</ArticleId><ArticleId IdType="pmc">PMC2664072</ArticleId><ArticleId IdType="pubmed">19279216</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayeem A, Sitkoff D, Krystek S Jr. 2006. A comparative study of available software for high-accuracy homology modeling: from sequence alignments to structural models. Protein Sci 15: 808&#x2013;824. 10.1110/ps.051892906</Citation><ArticleIdList><ArticleId IdType="doi">10.1110/ps.051892906</ArticleId><ArticleId IdType="pmc">PMC2242473</ArticleId><ArticleId IdType="pubmed">16600967</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng PC, Henikoff S. 2003. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 31: 3812&#x2013;3814. 10.1093/nar/gkg509</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkg509</ArticleId><ArticleId IdType="pmc">PMC168916</ArticleId><ArticleId IdType="pubmed">12824425</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu Q, Wang X, Shi M, Jin Q. 2015. A novel DYNC1H1 mutation causing spinal muscular atrophy with lower extremity predominance. Neurol Genet 1: e20. 10.1212/NXG.0000000000000017</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000017</ArticleId><ArticleId IdType="pmc">PMC4807905</ArticleId><ArticleId IdType="pubmed">27066557</ArticleId></ArticleIdList></Reference><Reference><Citation>Oiwa K, Sakakibara H. 2005. Recent progress in dynein structure and mechanism. Curr Opin Cell Biol 17: 98&#x2013;103. 10.1016/j.ceb.2004.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2004.12.006</ArticleId><ArticleId IdType="pubmed">15661525</ArticleId></ArticleIdList></Reference><Reference><Citation>Pampalakis G, Mitropoulos K, Xiromerisiou G, Dardiotis E, Deretzi G, Anagnostouli M, Katsila T, Rentzos M, Patrinos GP. 2019. New molecular diagnostic trends and biomarkers for amyotrophic lateral sclerosis. Hum Mutat 40: 361&#x2013;373. 10.1002/humu.23697</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.23697</ArticleId><ArticleId IdType="pubmed">30556231</ArticleId></ArticleIdList></Reference><Reference><Citation>Peeters K, Bervoets S, Chamova T, Litvinenko I, De Vriendt E, Bichev S, Kancheva D, Mitev V, Kennerson M, Timmerman V, et al. 2015. Novel mutations in the DYNC1H1 tail domain refine the genetic and clinical spectrum of dyneinopathies. Hum Mutat 36: 287&#x2013;291. 10.1002/humu.22744</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22744</ArticleId><ArticleId IdType="pubmed">25512093</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan L, Lv Q, Zhang Y. 2016. STRUM: structure-based prediction of protein stability changes upon single-point mutation. Bioinformatics 32: 2936&#x2013;2946. 10.1093/bioinformatics/btw361</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw361</ArticleId><ArticleId IdType="pmc">PMC5039926</ArticleId><ArticleId IdType="pubmed">27318206</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramani R, Krumholz K, Huang Y-F, Siepel A. 2019. PhastWeb: a web interface for evolutionary conservation scoring of multiple sequence alignments using PhastCons and PhyloP. Bioinformatics 35: 2320&#x2013;2322. 10.1093/bioinformatics/bty966</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty966</ArticleId><ArticleId IdType="pmc">PMC6596881</ArticleId><ArticleId IdType="pubmed">30481262</ArticleId></ArticleIdList></Reference><Reference><Citation>Reva B, Antipin Y, Sander C. 2011. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res 39: e118. 10.1093/nar/gkr407</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr407</ArticleId><ArticleId IdType="pmc">PMC3177186</ArticleId><ArticleId IdType="pubmed">21727090</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. 2015. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17: 405&#x2013;423. 10.1038/gim.2015.30</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2015.30</ArticleId><ArticleId IdType="pmc">PMC4544753</ArticleId><ArticleId IdType="pubmed">25741868</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney JP, Brayne C, Tobin K, Logroscino G, Glymour MM, Hardiman O. 2017. Benefits, pitfalls, and future design of population-based registers in neurodegenerative disease. Neurology 88: 2321&#x2013;2329. 10.1212/WNL.0000000000004038</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004038</ArticleId><ArticleId IdType="pubmed">28515268</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandelin A, Alkema W, Engstr&#xf6;m P, Wasserman WW, Lenhard B. 2004. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res 32: D91&#x2013;D94. 10.1093/nar/gkh012</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkh012</ArticleId><ArticleId IdType="pmc">PMC308747</ArticleId><ArticleId IdType="pubmed">14681366</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarlino S, Domi T, Pozzi L, Romano A, Pipitone GB, Falzone YM, Mosca L, Penco S, Lunetta C, Sansone V. 2020. Burden of rare variants in ALS and axonal hereditary neuropathy genes influence survival in ALS: insights from a next generation sequencing study of an Italian ALS cohort. Int J Mol Sci 21: 3346. 10.3390/ijms21093346</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21093346</ArticleId><ArticleId IdType="pmc">PMC7246633</ArticleId><ArticleId IdType="pubmed">32397312</ArticleId></ArticleIdList></Reference><Reference><Citation>Scoto M, Rossor AM, Harms MB, Cirak S, Calissano M, Robb S, Manzur AY, Mart&#xed;nez Arroyo A, Rodriguez Sanz A, Mansour S, et al. 2015. Novel mutations expand the clinical spectrum of DYNC1H1-associated spinal muscular atrophy. Neurology 84: 668&#x2013;679. 10.1212/WNL.0000000000001269</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001269</ArticleId><ArticleId IdType="pmc">PMC4336105</ArticleId><ArticleId IdType="pubmed">25609763</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah PR, Ahmad-Annuar A, Ahmadi KR, Russ C, Sapp PC, Robert Horvitz H, Brown RH Jr, Goldstein DB, Fisher EM. 2006. No association of DYNC1H1 with sporadic ALS in a case-control study of a northern European derived population: a tagging SNP approach. Amyotroph Lateral Scler 7: 46&#x2013;56. 10.1080/14660820500397057</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820500397057</ArticleId><ArticleId IdType="pubmed">16546759</ArticleId></ArticleIdList></Reference><Reference><Citation>Siokas V, Karampinis E, Aloizou AM, Mentis AA, Liakos P, Papadimitriou D, Liampas I, Nasios G, Bogdanos DP, Hadjigeorgiou GM, et al. 2020. CYP1A2 rs762551 polymorphism and risk for amyotrophic lateral sclerosis. Neurol Sci 42: 175&#x2013;182. 10.1007/s10072-020-04535-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04535-x</ArticleId><ArticleId IdType="pubmed">32592103</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokratous M, Lucia S, Bourinaris T, Marogianni C, Arnaoutoglou M, Patrikiou E, Ralli S, Markou A, Dardiotis E, Houlden H, et al. 2020. Prevalence of C9orf72 hexanucleotide repeat expansion in Greek patients with sporadic ALS. Amyotroph Lateral Scler Frontotemporal Degener 21: 470&#x2013;472. 10.1080/21678421.2020.1757115</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1757115</ArticleId><ArticleId IdType="pubmed">32338076</ArticleId></ArticleIdList></Reference><Reference><Citation>Stergachis AB, Haugen E, Shafer A, Fu W, Vernot B, Reynolds A, Raubitschek A, Ziegler S, LeProust EM, Akey JM, et al. 2013. Exonic transcription factor binding directs codon choice and affects protein evolution. Science 342: 1367&#x2013;1372. 10.1126/science.1243490</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1243490</ArticleId><ArticleId IdType="pmc">PMC3967546</ArticleId><ArticleId IdType="pubmed">24337295</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbot K, Feneberg E, Scaber J, Thompson AG, Turner MR. 2018. Amyotrophic lateral sclerosis: the complex path to precision medicine. J Neurol 265: 2454&#x2013;2462. 10.1007/s00415-018-8983-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8983-8</ArticleId><ArticleId IdType="pmc">PMC6182683</ArticleId><ArticleId IdType="pubmed">30054789</ArticleId></ArticleIdList></Reference><Reference><Citation>Talkowski ME, Rosenfeld JA, Blumenthal I, Pillalamarri V, Chiang C, Heilbut A, Ernst C, Hanscom C, Rossin E, Lindgren AM, et al. 2012. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell 149: 525&#x2013;537. 10.1016/j.cell.2012.03.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.03.028</ArticleId><ArticleId IdType="pmc">PMC3340505</ArticleId><ArticleId IdType="pubmed">22521361</ArticleId></ArticleIdList></Reference><Reference><Citation>Toropova K, Zalyte R, Mukhopadhyay AG, Mladenov M, Carter AP, Roberts AJ. 2019. Structure of the dynein-2 complex and its assembly with intraflagellar transport trains. Nat Struct Mol Biol 26: 823&#x2013;829. 10.1038/s41594-019-0286-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-019-0286-y</ArticleId><ArticleId IdType="pmc">PMC6774794</ArticleId><ArticleId IdType="pubmed">31451806</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripolszki K, Gampawar P, Schmidt H, Nagy ZF, Nagy D, Kliv&#xe9;nyi P, Engelhardt JI, Sz&#xe9;ll M. 2019. Comprehensive genetic analysis of a Hungarian amyotrophic lateral sclerosis cohort. Front Genet 10: 732. 10.3389/fgene.2019.00732</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2019.00732</ArticleId><ArticleId IdType="pmc">PMC6707335</ArticleId><ArticleId IdType="pubmed">31475037</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai M-J, Hsu C-Y, Sheu C-C. 2017. Amyotrophic lateral sclerosis. N Engl J Med 377: 1602. 10.1056/NEJMc1710379</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1710379</ArticleId><ArticleId IdType="pubmed">29048142</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsurusaki Y, Saitoh S, Tomizawa K, Sudo A, Asahina N, Shiraishi H, Ito J, Tanaka H, Doi H, Saitsu H, et al. 2012. A DYNC1H1 mutation causes a dominant spinal muscular atrophy with lower extremity predominance. Neurogenetics 13: 327&#x2013;332. 10.1007/s10048-012-0337-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-012-0337-6</ArticleId><ArticleId IdType="pubmed">22847149</ArticleId></ArticleIdList></Reference><Reference><Citation>Viollet LM, Swoboda KJ, Mao R, Best H, Ha Y, Toutain A, Guyant-Marechal L, Laroche-Raynaud C, Ghorab K, Barthez MA, et al. 2020. A novel pathogenic variant in DYNC1H1 causes various upper and lower motor neuron anomalies. Eur J Med Genet 63: 104063. 10.1016/j.ejmg.2020.104063</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmg.2020.104063</ArticleId><ArticleId IdType="pubmed">32947049</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlachakis D. 2009. Theoretical study of the Usutu virus helicase 3D structure, by means of computer-aided homology modelling. Theor Biol Med Model 6: 9. 10.1186/1742-4682-6-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4682-6-9</ArticleId><ArticleId IdType="pmc">PMC2707372</ArticleId><ArticleId IdType="pubmed">19555498</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I, Bell S, Cairns NJ, Miller TM, Baloh RH. 2009. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci 106: 18809&#x2013;18814. 10.1073/pnas.0908767106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908767106</ArticleId><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>